Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAZORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAZNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.7.4.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BN.1.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used